PhaseBio Pharmaceuticals, Inc. (PHAS)
Net Income
$27.84M
TTM · Period ending: · USD
PHAS Net Income
Latest reported$27.84Mperiod ending
Latest reported$27.84Mperiod ending
PHAS TTM Net Income (-$16.17M → $27.84M)
TTM net income
High-resolution chart · PNG
PHAS net income history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Net Income (USD) |
|---|---|
| 27,835,929 | |
| 15,937,929 | |
| -131,071 | |
| -118,336,000 | |
| -111,555,000 | |
| -111,018,000 | |
| -98,565,000 | |
| -79,521,000 | |
| -65,769,000 | |
| -46,859,000 | |
| -39,247,000 | |
| -32,784,000 | |
| -29,294,000 | |
| -26,736,000 | |
| -23,846,000 | |
| -21,513,000 | |
| -16,172,000 |